Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);癌, 肾细胞(Carcinoma, Renal Cell);综合疗法(Combined Modality Therapy);共病现象(Comorbidity);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);法国(France);人类(Humans);吲哚类(Indoles);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);分子靶向治疗(Molecular Targeted Therapy);肿瘤辅助疗法(Neoadjuvant Therapy);肾切除术(Nephrectomy);烟酰胺(Niacinamide);苯脲化合物(Phenylurea Compounds);吡咯类(Pyrroles);回顾性研究(Retrospective Studies);血栓切除术(Thrombectomy);血栓形成(Thrombosis);治疗结果(Treatment Outcome);腔静脉, 下(Vena Cava, Inferior)
DOI
10.1007/s00345-013-1088-1
PMID
23624719
发布时间
2022-03-17
- 浏览16

World journal of urology
109-14页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文